TABLE 2.
Baseline patient demographics of the study cohort
| Characteristics | Patients (n = 307) |
|---|---|
| Age (y) mean ± sd | 48.4 ± 14.8 |
| Gender male n (%) | 182 (59.3%) |
| Disease duration (y) mean ± sd | 15.0 ± 10.8 |
| Extension of disease n (%) | |
| Left‐sided colitis | 130 (42.3%) |
| Extensive or pan colitis | 172 (56.0%) |
| Missing data a | 5 (1.6%) |
| Therapy at time of colonoscopy n (%) | |
| No treatment | 14 (4.6%) |
| 5‐ASA | 234 (76.2%) |
| Corticosteroids | 74 (24.1%) |
| Immunomodulators | 68 (22.1%) |
| Biologics | 118 (38.4%) |
| Endoscopic activity | |
| Mayo endoscopic score n (%) | |
| Mayo 0 | 168 (54.7%) |
| Mayo 1 | 47 (15.3%) |
| Mayo 2 | 56 (18.2%) |
| Mayo 3 | 31 (10.1%) |
| Missing data a | 5 (1.6%) |
| UCEIS rectum n (%) | |
| Remission (≤1) | 209 (68.1%) |
| Mild (2–4) | 62 (20.2%) |
| Moderate (5–7) | 33 (10.7%) |
| Severe (>7) | 1 (0.3%) |
| Missing data a | 2 (0.6%) |
| UCEIS sigmoid n (%) | |
| Remission (≤1) | 219 (71.3%) |
| Mild (2–4) | 62 (20.2%) |
| Moderate (5–7) | 21 (6.8%) |
| Severe (>7) | 3 (1.0%) |
| Missing data a | 2 (0.6%) |
| PICaSSO Score rectum n (%) | |
| Remission (≤3) | 220 (71.7%) |
| Active (>3) | 85 (27.7%) |
| Missing data a | 2 (0.6%) |
| PICaSSO Score sigmoid n (%) | |
| Remission (≤3) | 229 (74.6%) |
| Active (>3) | 76 (24.8%) |
| Missing data a | 2 (0.6%) |
a
Missing data: These patients were not included in the overall analysis (302 patients analysed) due to solid stool present which preclude endoscopy assessment. 15 patients (4.9%) received non‐steroidal anti‐inflammatory drugs.